Annual Cash & Cash Equivalents
$4.93 M
-$28.54 M-85.27%
December 31, 2023
Summary
- As of February 8, 2025, VAXX annual cash & cash equivalents is $4.93 million, with the most recent change of -$28.54 million (-85.27%) on December 31, 2023.
- During the last 3 years, VAXX annual cash & cash equivalents has fallen by -$26.21 million (-84.17%).
- VAXX annual cash & cash equivalents is now -96.60% below its all-time high of $144.88 million, reached on December 31, 2021.
Performance
VAXX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.93 M
-$12.46 M-71.65%
December 31, 2023
Summary
- As of February 8, 2025, VAXX quarterly cash and cash equivalents is $4.93 million, with the most recent change of -$12.46 million (-71.65%) on December 31, 2023.
- Over the past year, VAXX quarterly cash and cash equivalents has dropped by -$28.54 million (-85.27%).
- VAXX quarterly cash and cash equivalents is now -96.60% below its all-time high of $144.88 million, reached on December 1, 2021.
Performance
VAXX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VAXX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.3% | -85.3% |
| 3 y3 years | -84.2% | -84.2% |
| 5 y5 years | +935.9% | - |
VAXX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -96.6% | at low | -96.6% | at low |
| 5 y | 5-year | -96.6% | +935.9% | -96.6% | at low |
| alltime | all time | -96.6% | +935.9% | -96.6% | at low |
Vaxxinity Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $4.93 M(-85.3%) | $4.93 M(-71.7%) |
| Sep 2023 | - | $17.39 M(-53.1%) |
| Jun 2023 | - | $37.06 M(+64.1%) |
| Mar 2023 | - | $22.59 M(-32.5%) |
| Dec 2022 | $33.48 M | $33.48 M(+77.4%) |
| Sep 2022 | - | $18.88 M(-82.7%) |
| Jun 2022 | - | $109.07 M(-12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $124.77 M(-13.9%) |
| Dec 2021 | $144.88 M(+365.2%) | - |
| Dec 2021 | - | $144.88 M(+62.1%) |
| Sep 2021 | - | $89.38 M(-19.4%) |
| Jun 2021 | - | $110.84 M(+255.9%) |
| Dec 2020 | $31.14 M(+6442.6%) | - |
| Dec 2020 | - | $31.14 M |
| Dec 2019 | $476.00 K | - |
FAQ
- What is Vaxxinity annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Vaxxinity?
- What is Vaxxinity annual cash & cash equivalents year-on-year change?
- What is Vaxxinity quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Vaxxinity?
- What is Vaxxinity quarterly cash and cash equivalents year-on-year change?
What is Vaxxinity annual cash & cash equivalents?
The current annual cash & cash equivalents of VAXX is $4.93 M
What is the all time high annual cash & cash equivalents for Vaxxinity?
Vaxxinity all-time high annual cash & cash equivalents is $144.88 M
What is Vaxxinity annual cash & cash equivalents year-on-year change?
Over the past year, VAXX annual cash & cash equivalents has changed by -$28.54 M (-85.27%)
What is Vaxxinity quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VAXX is $4.93 M
What is the all time high quarterly cash and cash equivalents for Vaxxinity?
Vaxxinity all-time high quarterly cash and cash equivalents is $144.88 M
What is Vaxxinity quarterly cash and cash equivalents year-on-year change?
Over the past year, VAXX quarterly cash and cash equivalents has changed by -$28.54 M (-85.27%)